Patents by Inventor Andrew Attila Pal

Andrew Attila Pal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250032007
    Abstract: Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration level. The glucose concentration level may be provided to a stored model to determine a state. The guidance may be determined based at least in part on the determined state.
    Type: Application
    Filed: October 11, 2024
    Publication date: January 30, 2025
    Inventors: Alexandra Elena CONSTANTIN, Scott M. BELLIVEAU, Naresh C. BHAVARAJU, Jennifer D. BLACKWELL, Eric S. COHEN, Basab DATTARAY, Anna Leigh DAVIS, Rian W. DRAEGER, Arturo GARCIA, John Michael GRAY, Hari HAMPAPURAM, Nathaniel David HEINTZMANN, Lauren Hruby JEPSON, Matthew Lawrence JOHNSON, Apurv Ullas KAMATH, Katherine Yerre KOEHLER, Phil MAYOU, Patrick Wile MCBRIDE, Michael Robert MENSINGER, Sumitaka MIKAMI, Andrew Attila PAL, Nicholas POLYTARIDIS, Philip Thomas PUPA, Eli REIHMAN, Peter C. SIMPSON, Tomas C. WALKER, Daniel Justin WIEDEBACK, Subrai Girish PAI, Matthew T. VOGEL
  • Publication number: 20250025046
    Abstract: The present disclosure relates to systems, devices and methods for receiving biosensor data acquired by a medical device, e.g., relating to glucose concentration values, and controlling the access and distribution of that data. In some embodiments, systems and methods are disclosed for monitoring glucose levels, displaying data relating to glucose values and metabolic health information, and controlling distribution of glucose data between applications executing on a computer, such as a smart phone. In some embodiments, systems and methods are disclosed for controlling access to medical data such as continuously monitored glucose levels, synchronizing health data relating to glucose levels between multiple applications executing on a computer, and/or encrypting data.
    Type: Application
    Filed: October 4, 2024
    Publication date: January 23, 2025
    Inventors: Michael Robert Mensinger, Esteban Cabrera, Jr., Eric Cohen, Nathaniel David Heintzman, Apurv Ullas Kamath, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Jorge Valdes
  • Patent number: 12193781
    Abstract: The present disclosure relates to systems, devices and methods for receiving biosensor data acquired by a medical device, e.g., relating to glucose concentration values, and controlling the access and distribution of that data. In some embodiments, systems and methods are disclosed for monitoring glucose levels, displaying data relating to glucose values and metabolic health information, and controlling distribution of glucose data between applications executing on a computer, such as a smart phone. In some embodiments, systems and methods are disclosed for controlling access to medical data such as continuously monitored glucose levels, synchronizing health data relating to glucose levels between multiple applications executing on a computer, and/or encrypting data.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: January 14, 2025
    Assignee: Dexcom, Inc.
    Inventors: Michael Robert Mensinger, Esteban Cabrera, Jr., Eric Cohen, Nathaniel David Heintzman, Apurv Ullas Kamath, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Jorge Valdes
  • Patent number: 12171547
    Abstract: Systems and methods are provided to determine a time to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a model or pattern. The time to deliver guidance may be calculated to be useful to a user in the management of a glucose concentration level.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: December 24, 2024
    Assignee: Dexcom, Inc.
    Inventors: Alexandra Elena Constantin, Scott M. Belliveau, Naresh C. Bhavaraju, Jennifer Blackwell, Eric Cohen, Basab Dattaray, Anna Leigh Davis, Rian Draeger, Arturo Garcia, John Michael Gray, Hari Hampapuram, Nathaniel David Heintzman, Lauren Hruby Jepson, Matthew Lawrence Johnson, Apurv Ullas Kamath, Katherine Yerre Koehler, Phil Mayou, Patrick Wile McBride, Michael Robert Mensinger, Sumitaka Mikami, Andrew Attila Pal, Nicholas Polytaridis, Philip Thomas Pupa, Eli Reihman, Peter C. Simpson, Tomas C. Walker, Daniel Justin Wiedeback, Subrai Girish Pai, Matthew T. Vogel
  • Publication number: 20240415430
    Abstract: Systems and methods disclosed here provide ways to discriminate fault types encountered in analyte sensors and systems and further provide ways to process such discriminated faults responsively based on sensor data, clinical context information, and other data about the patient or patient's environment. The systems and methods thus employ clinical context in detecting and/or responding to errors or faults associated with an analyte sensor system, and discriminating the type of fault, and its root cause, particularly as fault dynamics can appear similar to the dynamics of physiological systems, emphasizing the importance of discriminating the fault and providing appropriate responsive processing. Thus, the disclosed systems and methods consider the context of the patient's health condition or state in determining how to respond to the fault.
    Type: Application
    Filed: June 11, 2024
    Publication date: December 19, 2024
    Inventors: Stephen J. Vanslyke, Naresh C. Bhavaraju, Sebastian Böhm, Leif Bowman, Michael J. Estes, Arturo Garcia, Apurv U Kamath, Andrew Attila Pal, Thomas A. Peyser, Anna Leigh Davis, Daiting Rong, Disha Sheth, Peter C Simpson, Dmytro Sokolovsky
  • Patent number: 12133708
    Abstract: The present disclosure relates to systems, devices and methods for receiving biosensor data acquired by a medical device, e.g., relating to glucose concentration values, and controlling the access and distribution of that data. In some embodiments, systems and methods are disclosed for monitoring glucose levels, displaying data relating to glucose values and metabolic health information, and controlling distribution of glucose data between applications executing on a computer, such as a smart phone. In some embodiments, systems and methods are disclosed for controlling access to medical data such as continuously monitored glucose levels, synchronizing health data relating to glucose levels between multiple applications executing on a computer, and/or encrypting data.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: November 5, 2024
    Assignee: Dexcom, Inc.
    Inventors: Michael Robert Mensinger, Esteban Cabrera, Jr., Eric Cohen, Nathaniel David Heintzman, Apurv Ullas Kamath, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Jorge Valdes
  • Publication number: 20240304319
    Abstract: Disclosed are systems and methods for providing automated or semi-automated technical support for patients using medical devices, such as continuous glucose monitoring systems. Disclosed embodiments of automated tech support system include collection and storage of copies of streams of medical device data on multiple servers, analysis and comparison of data streams, remote tech support initiation and usage of the automated tech support system for providing improved products and services by storing and analyzing historical tech support data.
    Type: Application
    Filed: May 20, 2024
    Publication date: September 12, 2024
    Inventors: Andrew Attila PAL, Leif N. BOWMAN, Eric COHEN, Basab DATTARAY, Edward DAY, Apurv Ullas KAMATH, Aarthi MAHALINGAM, Dana Denea MINOR, Scott A. MOSS, Neil S. PURI, Eli REIHMAN, Conrad WOODS, Laurie L. BERG, Jorge VALDES
  • Patent number: 12048540
    Abstract: Systems and methods disclosed here provide ways to discriminate fault types encountered in analyte sensors and systems and further provide ways to process such discriminated faults responsively based on sensor data, clinical context information, and other data about the patient or patient's environment. The systems and methods thus employ clinical context in detecting and/or responding to errors or faults associated with an analyte sensor system, and discriminating the type of fault, and its root cause, particularly as fault dynamics can appear similar to the dynamics of physiological systems, emphasizing the importance of discriminating the fault and providing appropriate responsive processing. Thus, the disclosed systems and methods consider the context of the patient's health condition or state in determining how to respond to the fault.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: July 30, 2024
    Assignee: Dexcom, Inc.
    Inventors: Stephen J. Vanslyke, Naresh C. Bhavaraju, Sebastian Böhm, Leif N. Bowman, Michael J. Estes, Arturo Garcia, Apurv Ullas Kamath, Andrew Attila Pal, Thomas A. Peyser, Anna Leigh Davis, Daiting Rong, Disha B. Sheth, Peter C. Simpson, Dmytro Sokolovsky
  • Patent number: 12020811
    Abstract: Disclosed are systems and methods for providing automated or semi-automated technical support for patients using medical devices, such as continuous glucose monitoring systems. Disclosed embodiments of automated tech support system include collection and storage of copies of streams of medical device data on multiple servers, analysis and comparison of data streams, remote tech support initiation and usage of the automated tech support system for providing improved products and services by storing and analyzing historical tech support data.
    Type: Grant
    Filed: September 30, 2022
    Date of Patent: June 25, 2024
    Assignee: Dexcom, Inc.
    Inventors: Andrew Attila Pal, Leif N. Bowman, Eric Cohen, Basab Dattaray, Edward Day, Apurv Ullas Kamath, Aarthi Mahalingam, Dana Denea Minor, Scott A. Moss, Neil S. Puri, Eli Reihman, Conrad Woods, Laurie L. Berg, Jorge Valdes
  • Publication number: 20240126676
    Abstract: Disclosed are systems, methods, and articles for determining compatibility of a mobile application and operating system on a mobile device. In some aspects, a method includes receiving one or more data values from a mobile device having a mobile medical software application installed thereon, the data value(s) characterizing a version of the software application, a version of an operating system installed on the mobile device, and one or more attributes of the mobile device; determining whether the mobile medical software application is compatible with the operating system by at least comparing the received data value(s) to one or more test values in a configuration file; and sending a message to the mobile device based on the determining, the message causing the software application to operate in one or more of a normal mode, a safe mode, and a non-operational mode.
    Type: Application
    Filed: October 12, 2023
    Publication date: April 18, 2024
    Inventors: Issa Sami SALAMEH, Douglas William BURNETTE, Tifo Vu HOANG, Steven David KING, Stephen M. MADIGAN, Michael Robert MENSINGER, Andrew Attila PAL, Michael Ranen TYLER
  • Publication number: 20240071593
    Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.
    Type: Application
    Filed: October 24, 2023
    Publication date: February 29, 2024
    Inventors: Anna Leigh DAVIS, Scott M. BELLIVEAU, Naresh C. BHAVARAJU, Leif N. BOWMAN, Rita M. CASTILLO, Alexandra Elena CONSTANTIN, Rian W. DRAEGER, Laura J. DUNN, Gary Brian GABLE, Arturo GARCIA, Thomas HALL, Hari HAMPAPURAM, Christopher Robert HANNEMANN, Anna Claire HARLEY-TROCHIMCZYK, Nathaniel David HEINTZMAN, Andrea Jean JACKSON, Lauren Hruby JEPSON, Apurv Ullas KAMATH, Katherine Yerre KOEHLER, Aditya Sagar MANDAPAKA, Samuel Jere MARSH, Gary A. MORRIS, Subrai Girish PAI, Andrew Attila PAL, Nicholas POLYTARIDIS, Philip Thomas PUPA, Eli REIHMAN, Ashley Anne RINDFLEISCH, Sofie Wells SCHUNK, Peter C. SIMPSON, Daniel S. SMITH, Stephen J. VANSLYKE, Matthew T. VOGEL, Tomas C. WALKER, Benjamin Elrod WEST, Atiim Joseph WILEY
  • Patent number: 11837348
    Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.
    Type: Grant
    Filed: September 19, 2022
    Date of Patent: December 5, 2023
    Assignee: Dexcom, Inc.
    Inventors: Anna Leigh Davis, Scott M. Belliveau, Naresh C. Bhavaraju, Leif N. Bowman, Rita M. Castillo, Alexandra Elena Constantin, Rian W. Draeger, Laura J. Dunn, Gary Brian Gable, Arturo Garcia, Thomas Hall, Hari Hampapuram, Christopher Robert Hannemann, Anna Claire Harley-Trochimczyk, Nathaniel David Heintzman, Andrea Jean Jackson, Lauren Hruby Jepson, Apurv Ullas Kamath, Katherine Yerre Koehler, Aditya Sagar Mandapaka, Samuel Jere Marsh, Gary A. Morris, Subrai Girish Pai, Andrew Attila Pal, Nicholas Polytaridis, Philip Thomas Pupa, Eli Reihman, Ashley Anne Rindfleisch, Sofie Wells Schunk, Peter C. Simpson, Daniel S. Smith, Stephen J. Vanslyke, Matthew T. Vogel, Tomas C. Walker, Benjamin Elrod West, Atiim Joseph Wiley
  • Patent number: 11822457
    Abstract: Disclosed are systems, methods, and articles for determining compatibility of a mobile application and operating system on a mobile device. In some aspects, a method includes receiving one or more data values from a mobile device having a mobile medical software application installed thereon, the data value(s) characterizing a version of the software application, a version of an operating system installed on the mobile device, and one or more attributes of the mobile device; determining whether the mobile medical software application is compatible with the operating system by at least comparing the received data value(s) to one or more test values in a configuration file; and sending a message to the mobile device based on the determining, the message causing the software application to operate in one or more of a normal mode, a safe mode, and a non-operational mode.
    Type: Grant
    Filed: June 3, 2021
    Date of Patent: November 21, 2023
    Assignee: Dexcom, Inc.
    Inventors: Issa Sami Salameh, Douglas William Burnette, Tifo Vu Hoang, Steven David King, Stephen M. Madigan, Michael Robert Mensinger, Andrew Attila Pal, Michael Ranen Tyler
  • Patent number: 11766194
    Abstract: Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration level. The glucose concentration level may be provided to a stored model to determine a state. The guidance may be determined based at least in part on the determined state.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: September 26, 2023
    Assignee: Dexcom, Inc.
    Inventors: Alexandra Elena Constantin, Scott M. Belliveau, Naresh C. Bhavaraju, Jennifer Blackwell, Eric Cohen, Basab Dattaray, Anna Leigh Davis, Rian Draeger, Arturo Garcia, John Michael Gray, Hari Hampapuram, Nathaniel David Heintzman, Lauren Hruby Jepson, Matthew Lawrence Johnson, Apurv Ullas Kamath, Katherine Yerre Koehler, Phil Mayou, Patrick Wile McBride, Michael Robert Mensinger, Sumitaka Mikami, Andrew Attila Pal, Nicholas Polytaridis, Philip Thomas Pupa, Eli Reihman, Peter C. Simpson, Tomas C. Walker, Daniel Justin Wiedeback, Subrai Girish Pai, Matthew T. Vogel
  • Publication number: 20230260647
    Abstract: The subject matter disclosed herein provides methods for presenting glucose level data. Glucose data for a patient may be received. A current glucose level and a rate of change of the current glucose level may be determined based on the received glucose data. A first interface may be displayed on a screen of a device. The first interface may include a unitary icon. The unitary icon may display the current glucose level and a visualization of the rate of change. Related apparatus, systems, techniques, and articles are also described.
    Type: Application
    Filed: April 24, 2023
    Publication date: August 17, 2023
    Inventors: Katherine Yerre Koehler, Esteban Cabrera, JR., Eric Cohen, Mark Dervaes, Rian Draeger, Sheryl Sadsarin Gaano, Thomas Hall, Paul Kramer, Shawn Larvenz, Michael Robert Mensinger, Paul Noble-Campbell, Andrew Attila Pal, Eli Reihman, Brian Christopher Smith, Angela Marie Traven
  • Patent number: 11723560
    Abstract: Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration data sensed by a glucose concentration sensor. A host state change associated with the host glucose concentration data may be determined. A guidance message based at least in part on the host state change may also be determined. The guidance message may be delivered through a user interface.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: August 15, 2023
    Assignee: Dexcom, Inc.
    Inventors: Alexandra Elena Constantin, Scott M. Belliveau, Naresh C. Bhavaraju, Jennifer Blackwell, Eric Cohen, Basab Dattaray, Anna Leigh Davis, Rian Draeger, Arturo Garcia, John Michael Gray, Hari Hampapuram, Nathaniel David Heintzman, Lauren Hruby Jepson, Matthew Lawrence Johnson, Apurv Ullas Kamath, Katherine Yerre Koehler, Phil Mayou, Patrick Wile McBride, Michael Robert Mensinger, Sumitaka Mikami, Andrew Attila Pal, Nicholas Polytaridis, Philip Thomas Pupa, Eli Reihman, Peter C. Simpson, Tomas C. Walker, Daniel Justin Wiedeback
  • Patent number: 11714060
    Abstract: Systems and methods are provided that address the need to frequently calibrate analyte sensors, according to implementation. In more detail, systems and methods provide a preconnected analyte sensor system that physically combines an analyte sensor to measurement electronics during the manufacturing phase of the sensor and in some cases in subsequent life phases of the sensor, so as to allow an improved recognition of sensor environment over time to improve subsequent calibration of the sensor.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: August 1, 2023
    Assignee: Dexcom, Inc.
    Inventors: Naresh C. Bhavaraju, Becky L. Clark, Vincent P. Crabtree, Chris W. Dring, Arturo Garcia, Jason Halac, Jonathan Hughes, Jeff Jackson, Lauren Hruby Jepson, David I-Chun Lee, Ted Tang Lee, Rui Ma, Zebediah L. McDaniel, Jason Mitchell, Andrew Attila Pal, Daiting Rong, Disha B. Sheth, Peter C. Simpson, Stephen J. Vanslyke, Matthew D. Wightlin, Anna Leigh Davis, Hari Hampapuram, Aditya Sagar Mandapaka, Alexander Leroy Teeter, Liang Wang
  • Patent number: 11670418
    Abstract: The subject matter disclosed herein provides methods for presenting glucose level data. Glucose data for a patient may be received. A current glucose level and a rate of change of the current glucose level may be determined based on the received glucose data. A first interface may be displayed on a screen of a device. The first interface may include a unitary icon. The unitary icon may display the current glucose level and a visualization of the rate of change. Related apparatus, systems, techniques, and articles are also described.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: June 6, 2023
    Assignee: Dexcom, Inc.
    Inventors: Katherine Yerre Koehler, Esteban Cabrera, Jr., Eric Cohen, Mark Dervaes, Rian Draeger, Sheryl Sadsarin Gaano, Thomas Hall, Paul Kramer, Shawn Larvenz, Michael Robert Mensinger, Paul Noble-Campbell, Andrew Attila Pal, Eli Reihman, Brian Christopher Smith, Angela Marie Traven
  • Patent number: 11656195
    Abstract: Systems and methods are provided that address the need to frequently calibrate analyte sensors, according to implementation. In more detail, systems and methods provide a preconnected analyte sensor system that physically combines an analyte sensor to measurement electronics during the manufacturing phase of the sensor and in some cases in subsequent life phases of the sensor, so as to allow an improved recognition of sensor environment over time to improve subsequent calibration of the sensor.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: May 23, 2023
    Assignee: Dexcom, Inc.
    Inventors: Naresh C. Bhavaraju, Becky L. Clark, Vincent P. Crabtree, Chris W. Dring, Arturo Garcia, Jason Halac, Jonathan Hughes, Jeff Jackson, Lauren Hruby Jepson, David I-Chun Lee, Ted Tang Lee, Rui Ma, Zebediah L. McDaniel, Jason Mitchell, Andrew Attila Pal, Daiting Rong, Disha B. Sheth, Peter C. Simpson, Stephen J. Vanslyke, Matthew D. Wightlin, Anna Leigh Davis, Hari Hampapuram, Aditya Sagar Mandapaka, Alexander Leroy Teeter, Liang Wang
  • Publication number: 20230027200
    Abstract: Disclosed are systems and methods for providing automated or semi-automated technical support for patients using medical devices, such as continuous glucose monitoring systems. Disclosed embodiments of automated tech support system include collection and storage of copies of streams of medical device data on multiple servers, analysis and comparison of data streams, remote tech support initiation and usage of the automated tech support system for providing improved products and services by storing and analyzing historical tech support data.
    Type: Application
    Filed: September 30, 2022
    Publication date: January 26, 2023
    Inventors: Andrew Attila PAL, Leif N. BOWMAN, Eric COHEN, Basab DATTARAY, Edward DAY, Apurv Ullas KAMATH, Aarthi MAHALINGAM, Dana Denea MINOR, Scott A. MOSS, Neil S. PURI, Eli REIHMAN, Conrad WOODS, Laurie L. BERG, Jorge VALDES